Amy Olsen
Family · Vernal, UTNPI 1598991275
Payments from drug & device makers
Across 76 payments — averaging $18.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$422
- Lilly USA, LLC$181
- Corcept Therapeutics$117
- Amgen$117
- Boehringer Ingelheim$70
- Globus Medical$70
- plus $430 from 16 others
What the payments were for
- Food & beverage$1,407100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 23 | $422 |
| Lilly USA, LLC | 11 | $181 |
| Corcept Therapeutics | 7 | $117 |
| Amgen | 4 | $117 |
| Boehringer Ingelheim | 4 | $70 |
| Globus Medical | 1 | $70 |
| Novo Nordisk | 4 | $66 |
| Organon | 3 | $64 |
| Merck | 3 | $45 |
| AbbVie | 2 | $35 |
| Idorsia Pharmaceuticals US Inc | 2 | $30 |
| Pfizer | 2 | $29 |
| Axsome Therapeutics, Inc. | 1 | $20 |
| Bayer | 1 | $18 |
| BETA Bionics, Inc. | 1 | $17 |
| Sobi, Inc | 1 | $17 |
| Neurocrine Biosciences, Inc. | 1 | $16 |
| Xeris Pharmaceuticals, Inc. | 1 | $16 |
| Ardelyx, Inc. | 1 | $15 |
| Boston Scientific | 1 | $15 |
| Tandem Diabetes Care, Inc. | 1 | $13 |
| Medtronic | 1 | $13 |
How this compares
$1,407 in reported general payments places this provider in the 75th percentile of 1,460 family providers in Utah.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 17 | $14,266 |
| Nabumetone | 18 | $925 |
| Levothyroxine Sodium | 117 | $910 |
| SynthroidLevothyroxine Sodium | 11 | $815 |
| Duloxetine Hcl | 22 | $755 |
| Atorvastatin Calcium | 69 | $708 |
| Estradiol (Once Weekly)Estradiol | 13 | $619 |
| Gabapentin | 28 | $503 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 15 | $319 |
| Omeprazole | 42 | $304 |
| ProgesteroneProgesterone, Micronized | 14 | $288 |
| Losartan Potassium | 34 | $254 |
| Lisinopril | 46 | $218 |
| Fluticasone Propionate | 17 | $194 |
| Metformin Hcl | 29 | $157 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $66 | $14,26617 claims |
| AbbVieSynthroid | $35 | $81511 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 1,460 family providers in Utah.
Other family in Vernal
- Annemarie RousseauVernal$12K
- Riley WorthSandy$1.1M
- Katrina BawdenSalt Lake City$446K
- Cortnee RomanSalt Lake City$374K
- Jared ThorleySalt Lake City$368K
- Stephanie GodfreyLindon$358K
- Mary SteinbackSalt Lake City$189K
- Shannon FordSouth Jordan$186K
- Jennalyn MayeuxSalt Lake City$151K
- Brett RawlinsKaysville$149K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.